The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksATMA.L Regulatory News (ATMA)

  • There is currently no data for ATMA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reissued Notice to Bondholders

30 Dec 2020 17:30

RNS Number : 1995K
ATLAS Mara Limited
30 December 2020
 

REISSUED NOTICE

THIS NOTICE DOES NOT CONSTITUTE OR FORM PART OF, AND SHOULD NOT BE CONSTRUED AS, AN OFFER FOR SALE, EXCHANGE OR SUBSCRIPTION OF, OR A SOLICITATION OF ANY OFFER TO BUY EXCHANGE OR SUBSCRIBE FOR, ANY SECURITIES OF THE ISSUER OR ANY OTHER ENTITY.

THIS NOTICE IS IMPORTANT AND REQUIRES THE IMMEDIATE ATTENTION OF BONDHOLDERS.

If Bondholders are in any doubt as to the action they should take, they should seek their own financial and legal advice, including as to any tax consequences, immediately from their broker, bank manager, solicitor, accountant or other independent financial, tax or legal adviser.

FURTHER INFORMATION REGARDING THE MATTERS REFERRED TO IN THIS ANNOUNCEMENT IS AVAILABLE IN THE MORE DETAILED ANNOUNCEMENT ISSUED BY THE COMPANY ON 29 DECEMBER, WHICH CAN BE FOUND AT https://www.atlasmara.com/investor-relations/regulatory-filings-rns/ AND BONDHOLDERS ARE ENCOURAGED TO READ THIS ANNOUNCEMENT IN CONJUNCTION WITH THE SAME.

29 December 2020

_________________________________________________

NOTICE

to each of the holders (the "Bondholders") of the

$63,400,000 and $17,400,000 8.00 per cent. Secured Convertible Bonds due 2020, consolidated into a single series (ISINs: XS1298407229 and XS1297883214) (the "Bonds")

issued by

Atlas Mara Limited

(a private limited company incorporated under the laws of the British Virgin Islands with registered number 1800950) (the "Company")

_________________________________________________

NOTICE IS HEREBY GIVEN that the Company has entered into a new secured facility agreement with a fund entity managed by UBS O'Connor LLC (the "New Money Facility") and a standstill agreement with certain creditors in respect of its group's financing arrangements (the "Standstill Agreement").

The New Money Facility will benefit from a first ranking security interest over certain assets owned by the Company and which are not, as at the date of the Standstill Agreement, subject to any security interest.

The creditors that have entered into the Standstill Agreement include an ad hoc group of Bondholders representing over 50% by value of the Bonds (the "Ad Hoc Group"). Among other things, the Standstill Agreement provides that, in consideration for the consents and forbearances contained therein (including in relation to the granting of the security package with respect to the New Money Facility), the Company will grant additional security in the form of a silent second lien over the assets securing the New Money Facility in favour of the trustee with respect to the Bonds (the "Trustee") for the benefit of the Bondholders.

Pursuant to the Standstill Agreement, the members of the Ad Hoc Group have agreed not to take enforcement action with respect to the Bonds when they mature on 31 December 2020. This forbearance period will last until 31 March 2021 or the Standstill Agreement is terminated in accordance with its terms, whichever happens earlier.

Further details with respect to the New Money Facility and the Standstill Agreement can be found in Atlas Mara Limited's announcement of 29 December 2020, which can be found at https://www.atlasmara.com/investor-relations/regulatory-filings-rns.

Bondholders who would like to receive a copy of the Standstill Agreement should contact the Company via the contact details below. To receive the Standstill Agreement, the Company must receive appropriate evidence of proof of holdings from the requesting Bondholders and may require the relevant Bondholders to enter into suitable confidentiality undertakings.

The Company is working with the Ad Hoc Group and the Trustee to finalise the documents required to give effect to the silent second lien referred to above, which are expected to include an intercreditor agreement and a silent second lien security document. The Company, the Ad Hoc Group and the Trustee are considering the process required to grant the second lien, including whether any formal consent will be required from the Bondholders, and will provide further details in the new year. If required, such consent will either take the form of an "Extraordinary Resolution" under the Bonds trust deed (which would require consent from at least 75 per cent. of Bondholders voting at a meeting of Bondholders) or a written resolution signed by or on behalf of the holders of at least 90 per cent. in principal amount of the Bonds.

Bondholders who are not members of the Ad Hoc Group are encouraged to contact the Company using the contact details below for further information with respect to this consent process. Bondholders may also wish to copy the legal advisers to the Ad Hoc Group whose details are set out below.

The Company: bondholdernotices@atlasmara.com

The Ad Hoc Group: Dentons US LLPbrian.greer@dentons.com+1 212 768 6819

 

 

 

DISCLAIMER - INTENDED ADDRESSEES

This announcement does not constitute an offer of any securities for sale.

The Bonds and any ordinary shares which may be delivered upon conversion of the Bonds have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act").

The distribution of this announcement in certain jurisdictions may be restricted by law. Persons into whose possession this announcement comes are required to inform themselves about and to observe any such restrictions.

This announcement has been prepared solely for information purposes and is not an offer (or a solicitation of an offer) to buy or sell any securities in any jurisdiction.

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRWPGMPPUPUGMU
Date   Source Headline
23rd Nov 20214:35 pmRNSPrice Monitoring Extension
10th Nov 20214:41 pmRNSSecond Price Monitoring Extn
10th Nov 20214:35 pmRNSPrice Monitoring Extension
2nd Nov 20214:41 pmRNSSecond Price Monitoring Extn
2nd Nov 20214:35 pmRNSPrice Monitoring Extension
27th Oct 20214:40 pmRNSSecond Price Monitoring Extn
27th Oct 20214:35 pmRNSPrice Monitoring Extension
25th Oct 20215:50 pmRNSStrategic Update and Voluntary Delisting
11th Oct 20215:51 pmRNSNotice of Results of Meeting of Noteholders
8th Oct 20214:41 pmRNSSecond Price Monitoring Extn
8th Oct 20214:36 pmRNSPrice Monitoring Extension
16th Sep 20214:40 pmRNSSecond Price Monitoring Extn
16th Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20218:51 amRNS2020 Annual Financial Statements
31st Aug 20216:28 pmRNS2020 Year-End Results
25th Aug 20212:49 pmRNSBPR Sale Completion to KCB & Notice to Investors
22nd Jul 202112:35 pmRNSSuccessful Dismissal of TLG Petition
14th Jul 20215:13 pmRNSAtlas Mara Announces Successful Restructuring
1st Jul 20217:30 amRNSSuspension - Atlas Mara Limited
1st Jul 20217:00 amRNSHalt in Trading & Upcoming Reporting
29th Jun 20211:59 pmRNSExtension of Accounting Reference Date
19th May 20217:00 amRNSRestructuring Discussions and Strategic Review
5th May 20217:12 amRNSStrategic Review and Restructuring Discussions
19th Apr 20217:00 amRNSStrategic Transaction with Access Bank Plc
12th Apr 202111:17 amRNSUpdate on Standstill and Statement re Norsad
1st Apr 20217:02 amRNSUpdate on Standstill and In Principle Agreement
22nd Mar 20214:41 pmRNSSecond Price Monitoring Extn
22nd Mar 20214:36 pmRNSPrice Monitoring Extension
10th Mar 20217:00 amRNSNotice of Results of Meeting of Noteholders
5th Mar 20216:29 pmRNSVoting Rights & Director/PDMR Shareholding Update
26th Feb 20214:40 pmRNSSecond Price Monitoring Extn
26th Feb 20214:35 pmRNSPrice Monitoring Extension
17th Feb 20218:34 amRNSUpdate on Standstill and Statement regarding TLG
25th Jan 20214:40 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
25th Jan 20217:30 amRNSAtlas Mara Addresses Market Rumours
19th Jan 20214:41 pmRNSSecond Price Monitoring Extn
19th Jan 20214:35 pmRNSPrice Monitoring Extension
5th Jan 20216:16 pmRNSNotification of Major Interest in Shares
4th Jan 20215:46 pmRNSRepurchase of Shares and Total Voting Rights
31st Dec 202012:40 pmRNSSecond Price Monitoring Extn
31st Dec 202012:35 pmRNSPrice Monitoring Extension
30th Dec 20205:30 pmRNSReissued Notice to Bondholders
29th Dec 20209:00 amRNSNotice to Bondholders
29th Dec 20207:03 amRNSNew Financing and Standstill Agreement
14th Dec 20206:20 pmRNSNotification of Major Interest in Shares
14th Dec 20206:16 pmRNSNotification of Major Interest in Shares
26th Nov 20207:00 amRNSStrategic Transaction with KCB Group Plc
24th Nov 20204:41 pmRNSSecond Price Monitoring Extn
24th Nov 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.